Anicet Okinga is the new Pharmaceutical Patent Senior Advisor at Licks Attorneys

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Anicet Okinga is the new Pharmaceutical Patent Senior Advisor at Licks Attorneys

Sponsored by

Licks_Brazil.png

Licks Attorneys announce Anicet Okinga as the new Pharmaceutical Patent Senior Advisor at Licks Attorneys

Licks Attorneys is pleased to announce the hiring of Prof. Dr. Anicet Okinga, DDS Oral and Dental Surgeon, PharmD, Doctor in Pharmaceutical Sciences, as the firm’s new Pharmaceutical Patents Senior Advisor. His arrival reinforces the firm’s strategic focus on scientific excellence, high complexity patent matters, and technical depth in the pharmaceutical sector.

Prof. Dr. Okinga brings a multidisciplinary background that spans dentistry, pharmacy, and advanced research in clinical and experimental pathophysiology. His scientific experience includes work in pharmacology, neuroscience, inflammation, metabolism, and bioactive compounds—knowledge that strengthens the firm’s ability to support clients in highly technical patent disputes and prosecution strategies.

From 2017 to 2026, he served as a Patent Examiner in the Pharmaceuticals Art Unit at the Brazilian Patent and Trademark Office (BRPTO), where he conducted substantive examination of applications involving pharmaceutical compounds, formulations, delivery systems, and medical uses. His perspective as a former examiner adds a valuable regulatory and procedural dimension to the team’s work, supporting informed and effective strategies for innovation driven clients.

His training includes the Cycle Long “Brevets d’invention” at the Université de Strasbourg (UNISTRA) and advanced programs from WIPO, the EPO, and the European Patent Academy, with focus on patent drafting, examination procedures, unity of invention, and European patent law.

Beyond his technical background, Prof. Dr. Okinga has contributed to governance and diversity initiatives, serving as Honorary Counselor at the State Council for the Rights of Black People and the Promotion of Racial Equality in Rio de Janeiro (CEDINE RJ) and collaborating with the Racial Equality Commission of the Brazilian Bar Association (OAB/RJ). He also chaired the BRPTO Careers and Positions Commission between 2021 and 2023 and holds a LideraGov 4.0 certification for innovation oriented public leadership.

Anicet Okinga arrival strengthens Licks Attorneys’ capacity to navigate the intersection of science, regulation, and intellectual property, offering clients a deeper technical foundation in pharmaceutical innovation and patent protection.

more from across site and SHARED ros bottom lb

More from across our site

Six hires across the IP spectrum reflect Orrick’s efforts to better serve tech clients across the IP lifecycle
David Stone, partner at White & Case, argues that the government’s planned reforms will modernise and futureproof UK design law, but leave two of the thorniest problems unresolved
Max Scott will join the firm’s IP transactions group in California, becoming the latest Weil IP partner to secure their future
Yonatan Drori, attorney at Drori-Stav IP in Israel, explains why foreign counsel must treat Israel’s patent disclosure requirements as an ongoing obligation, rather than a one-off formality
From Japan to Southeast Asia, domestic and regional firms picked up some of the biggest prizes, while key foreign players maintained momentum
Earlier this month, Managing IP had exclusively reported that the French arm of Taylor Wessing was minded to pull out of the deal
Our latest podcast examines how Weil’s IP practice evolved, where its practitioners could (and will) go next, and which firms and markets stand to benefit from the redistribution of talent
Former Latham partner Chris Henry and transactions lawyer Liza Cotter are heading to the firm as Weil’s IP practice starts to disperse
Rival IP teams return to court for a closely watched appeal over AI and copyright, but observers hoping for answers to some of the technology’s biggest legal questions may be left disappointed
Eight years after its launch, members of the Australian patent firm’s Singapore office explain its growth strategy over the past year
Gift this article